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Background: Transanal Minimally Invasive Surgery has proven to be a viable alternative in the
treatment of rectal tumors; however, rectal wound closure can be challenging. We describe
our  experience with this procedure using the vloc suture device.
Resume: Eight successful Transanal Minimally Invasive Surgery with primary wound closure
using vloc were performed in 5 men, 62 years mean age; all cases had pre-operative diagnosis
of  adenoma with high-grade dysplasia. The surgical anatomic–pathologic results showed 6
adenomas with high-grade dysplasia and 2 well differentiated adenocarcinomas, limited
to  the upper third of the submucosa (pT1SM1) without lymphatic or vascular invasion. All
lesions were resected with negative margins. No patient reported during follow-up rectal
pain, fecal incontinence or bleeding.
Conclusion: The use of vloc in rectal wound closure during Transanal Minimally Invasive
Surgery is secure and facilitates the procedure.
© 2015 Sociedade Brasileira de Coloproctologia. Published by Elsevier Editora Ltda. All
rights reserved.
TAMIS  com  excisão  parcial  do  mesorreto  e  fechamento  primário  da  ferida
retal  usando  vloc
Palavras-chave:
TES
r  e  s  u  m  o
Tema: Cirurgia Minimamente Invasiva Transanal (TAMIS) tem provado ser uma  alternativa
viável para o tratamento de tumores do reto, porém o fechamento da ferida rectal pode
TAMIS
Câncer retal
Vloc
Excisão parcial do mesorreto
ser  desaﬁadante. Nós descrevemos nossa experiência com este procedimento utilizando o
dispositivo de sutura vloc.
Resumo: Oito TAMIS foram realizados com sucesso com o fechamento primário da ferida
usando vloc, cinco homens, com idade média de 62 anos, todos os casos tiveram diagnóstico
pré-operatório de adenoma com displasia de alto grau. Os resultados anátomo-patológicos
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pós-operatório demonstraram: 6 adenomas com displasia de alto grau e 2 adenocarcinomas
bem diferenciados, limitado ao terc¸o superior da submucosa (pT1SM1), sem invasão linfática
ou  vascular. Todas as lesões foram ressecados com margens negativas. Nenhum paciente
relatou durante o seguimento dor rectal, incontinência fecal ou sangramento.
Conclusão: O uso de vloc no fechamento da ferida retal durante TAMIS é seguro e facilita o
procedimento.
©  2015 Sociedade Brasileira de Coloproctologia. Publicado por Elsevier Editora Ltda.
Todos os direitos reservados.
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The patient underwent previous mechanical bowel prepara-
tion, and the procedure is performed under general anesthesia
in the lithotomy position. The patient’s position usually isntroduction
ransanal Endoscopic Surgery (TES) has been performed with
raditional platforms such as TEM (Transanal Endoscopic
icrosurgery) and TEO (Transanal Endoscopic Operation) and
ewer techniques like TAMIS (Transanal Minimally Invasive
urgery).1,2
TAMIS procedure is the transanal use of disposable mul-
iple channels laparoscopic ports, associated with the use of
rdinary laparoscopic equipment and CO2 insufﬂation (pneu-
orectum). It can be performed with various devices like
ILSTM port (Covidien), SSLTM (Ethicon), Gelpoint (Applied
edical) or adaptations of anal dilator with surgical gloves.2
The risk of lymph node involvement in adenocarcinomas
imited to submucosa (pT1) is 10–34%.3 Despite recent studies
ave shown that in the treatment of rectal adenocarcinoma,
ES is associated with higher recurrence rates when com-
ared to radical surgery (2.9–12% of the cases submitted to
ES and 0.5% submitted to radical surgery),4 overall survival
ates did not differ between the two groups. This is probably
ecause patients undergoing TES follow rigorous surveillance
rotocols and when relapse occurs, they are referred to radical
urgery or adjuvant treatment. Multicenter study concluded
hat TEM can be beneﬁcial in very selected cases of rectal
ancer, taking into account the degree of penetration into
he submucosa (pT1SM1), tumor diameter (less 3 cm), absence
f lymphatic or vascular invasion and well differentiated
umor,3,4 in this situation local recurrence rate of less than
% was reported when treated by TES, which is similar to the
esults of radical surgery, but with a signiﬁcant reduction in
orbidity and mortality.
Variable rates of complications are reported with TES, espe-
ially related to suture dehiscence. This is more  prevalent in
atients undergoing neoadjuvant therapy therpy.5
TES has three steps. First step: initial transanal installation
f the device, when performing TEM and TEO the introduction
f a rigid surgical proctoscopy and hold it to the operating
able; the patient will be positioned according to the location
f the lesion; in TAMIS no attachment to the operating table
s necessary and the device can be sutured to the perianal
kin; usually it is possible to perform most procedures in
he lithotomy position. Second step: excision, where in cases
f partial thickness resection is not necessary to close the
ound; we  can easily identify the submucosa plane dissection
ith visualization of the circular orientation of the muscle
bers. In cases of Partial Mesorectal Excision (PME) with full
hickness resection of rectal wall, the perirectal fat is also
asily identiﬁed.1Third step: in cases of PME, usually primary wound clo-
sure is indicated, although the possibility to leave it open
without major complications is described. The realization
of suture in a narrow operating ﬁeld, where the conﬂict of
tools frequently occurs, is tough and it is not always possible.
Several techniques have been described: continuous sutures
anchored with conventional laparoscopic or silver clips; auto-
matic continuous sutures (endostich), separated stitches with
extracorporeal knot, anchored stitches and closure using tra-
ditional anal retractors. The difﬁculty or impossibility of
wound closure and the inadvertent opening of the abdominal
cavity have been described for cases of conversion to tradi-
tional transanal surgery or laparotomy or laparoscopy.6
The objective of this study is to report the use of vloc device
(Fig. 1) to close the rectal wound in TAMIS procedure.
Methods
Surgical  technique  installation  of  TAMISFig. 1 – Vloc device.
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Fig. 2 – SILSTM port device.
Fig. 3 – SSLTM port device.
margins.
Colonoscopy with biopsy was performed in all patients and
Magnetic Resonance Imaging (MRI) of abdomen and pelvisindependent of the location of the lesions (but in our previ-
ous experience, in one anterior bulky lesion we have opted
to the prone position).1 Next is introduction of SILSTM port
(Covidien, USA) (Fig. 2) or SSLTM (Ethicon, USA) (Fig. 3) and one
5 mm or 12 mm optic and 2 clamps through device holes and
ﬁxation to the perianal skin, if necessary and CO2 insufﬂation
to maintain a satisfactory level of rectal distension (usually
12–15 mmHg).Fig. 4 – Final aspect of the rectal wound closure.
Dissection  of  the  lesion
Radial demarcation of the tumor; excision of the lesion,
including the full thickness of the rectal wall and adjacent
perirectal fat; this step can be performed either with conven-
tional electric scalpel or other energy sources like bipolar or
ultrasonic scalpel. In cases that used SILS, we  took the speci-
men  out together with the device. Reintroduction of SILS with
new insufﬂation.
Closure  of  wound
In these cases where the perirectal fat was exposed, closure of
rectal wall was performed using vloc device; after the transﬁx-
ation of the edges of the wound, the needle is passed through
the loop located at its end starting a continuous suture, tak-
ing into account that the suture automatically anchors in the
wound; thanks to micro-spicules, it is not possible to loosen
the suture or return the last passage. When the defect is too
large we  used more  than one suture. When the suture is ﬁn-
ished it is not necessary to perform knot or anchor with clip,
just cut it (Fig. 4). After reviewing hemostasis and the suture,
withdraw the device.
Eight PME procedures with primary wound closure using
vloc were performed and compared by gender, age, indication
and surgical complications, operative time, number of sutures,
positive margins and mortality.a
Results
Eight procedures were performed in 5 men, 62 years mean
age, and all cases had pre-operative diagnosis of adenoma
with high-grade dysplasia. Four had undergone previous
colonoscopic polypectomy (piece meal resection) with positivea To watch the video of this procedure access: https://www.
youtube.com/watch?v=lLE0OkV4URU.
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Fig. 6 – Surgical specimen.Fig. 5 – MRI  of pelvis showing rectal tumor.
ith a speciﬁc protocol for staging of rectal tumors (Fig. 5);
here were no suspicion of invasion of muscle layer of the
ectum or suspect lymph nodes.
In 7 cases SILSTM port device (Covidien, USA) was used, and
n one case SSLTM (Ethicon, USA). The average lesion size was
.5 cm.  The average distance from the anal verge was 6.2 cm.
The mean duration of the procedures was 95 min; it was
ossible to perform the primary closure of the rectal defect in
ll cases using the vloc suture device (Covidien, USA). An aver-
ge of 1.5 suture per procedure was used; the average hospital
tay was 2.3 days.
The anatomic–pathologic results showed 6 adenomas with
igh-grade dysplasia and 2 well differentiated adenocarcino-
as, limited to the upper third of the submucosa (pT1SM1)
ithout lymphatic or vascular invasion and negative lymph
odes; in these 2 cases the option of radical surgery was
ffered, but they refused this alternative. All lesions were
esected with negative margins (Fig. 6).
No patient reported during follow-up rectal pain, fecal
ncontinence or bleeding. One patient had a hemorrhoidal
hrombosis treated with medications. All patients underwent
exible sigmoidoscopy 30 days after the procedure (Fig. 7); no
ehiscence wound was diagnosed. There were no deaths. The
ean follow-up is 11 months, without recurrence. No adju-
ant treatment was necessary.
iscussion
hen we compare these results with our previous experi-
nce (ﬁrst series in South America), performing a total of 12
AMIS procedures, the wound closure using vloc device seems
o decrease surgical time and avoid the use of anal retractors
o facilitate the closure of the rectal wall defect. The wound
losure in TES is generally the most laborious part of the proce-
ure and responsible for conversion. Vloc avoids the necessity
f intracorporeal knot and facilitates further closure of the
ound by the continuous anchoring as the suture continues.Fig. 7 – Surgical postoperative view of scar on rectal wall.
The use of more  than one suture facilitates the closure of
larger wounds because it prevents the narrowing of the rectal
lumen as the suture is performed.
Complications occur in about 4% of cases of TES6,7 and
include bleeding, perforation, wound dehiscence, abscesses,
incontinence, stenosis and subcutaneous emphysema.
Among all the complications, bleeding and wound dehis-
cence are the most common surgical complications (27.4%
and 13.7%, respectively), and urinary tract infection is the
most common overall complication (21.1%). Most surgical
complications are treated conservatively and only 2% require
additional procedures.7–9
Complications and wound dehiscence occur more  fre-
quently in irradiated patients than non-irradiated (33 and
j). 2 0
r
1
1
1
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25.6% vs 5.3 vs 0%, respectively)5; small dehiscence are
more prevalent (21%), large dehiscence are uncommon (4.7%).
Marks10 also reported that 91% of dehiscence was treated con-
servatively, with a diagnosis mean time of 3.8 weeks.
The learning curve inﬂuences on conversion rates, postop-
erative complications and the height and size of the resected
lesions.9
High complication rates after radiotherapy 10 (57%) have
been reported with TES; rectal pain is the most frequent man-
ifestation (34%) and was classiﬁed as grade II and III in over 70%
of patients.9 Perez et al.11 showed high index of dehiscence
and rectal pain after radiotherapy compared to non-irradiated
group (61% vs 23%); the median time from diagnosis was
one week and a eight weeks healing time, 8% developed late
complications, all after diagnosis of suture dehiscence. Rec-
tal stenosis has been described in 5% in both groups after
wound complications. The majority (93%) of the patients were
managed conservatively.
Saclarides12 draws attention to the care of the wound clo-
sure after full excision of the rectal wall in TES, as transverse
wound closure with absorbable sutures. Multiple sutures are
preferable for closure of large wounds; in these cases the revi-
sion of the permeability of the rectal lumem after the end of
the suture is always mandatory, in order to avoid stenosis.
A question that remains unclear is whether the TES tech-
niques are comparable. Prospective studies have not been
performed yet, comparing the former platforms and TAMIS.
One author13 in an experimental study reported that TAMIS
is related to high failure rates (30%) when compared to TEM,
in contrast with reports by other authors who have shown
high success rates with TAMIS.2 Strangely, it was described
too that the time for the installation of TAMIS device is greater
than TEM or TEO. In relation to costs, contrasting results have
also been described in relation to the different methods of
TES, with these reports: TEO D 1920, TEM D 2310 and TAMIS
D 2220.14
A recent review2 found that 390 procedures had been
described using TAMIS, the average lesion size was 3.1 cm,
the average distance from the anal margin was 7.6 cm,  pos-
itive margins occurred in 4.3%, and fragmentation of surgical
specimens in 4.1%. Conversion was reported in 2.3% of cases.
Complications occurred in 7.4%, the most common being
bleeding, pneumo-scrotum, subcutaneous emphysema, fever,
suture dehiscence and peritoneal perforation.
TAMIS have been most commonly performed under gen-
eral anesthesia, although the use of spinal anesthesia15 with
good results was described. Wright16 reports safety release of
the patient after 48 h and might be possible to conduct TES in
day hospital system.
New TAMIS applications as transanally proctectomy with
Total Mesorectum Excision (TME)2,17 seem to be promising and
may indicate that the method is suitable for the treatment of
advanced rectal tumors and perhaps superior to other tech-
niques of TES in speciﬁc situations. Improvement of devices
used in TAMIS may allow treatment of lesions located in
upper rectum,18 correcting the most important limitation of
the method when compared with TEM and TEO.Like the other techniques of TES, the careful selection of
patients with rectal tumor to undergo PME  by TAMIS is critical
to achieve good results.
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Conclusion
We conclude that the use of vloc in wound closure during
TAMIS is secure and facilitates the procedure.
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